$62.43
Value $3.0B
NHI and PLD stock compared: price, dividend, valuation and results, from SEC filings.
$62.43
Value $3.0B
$125.22
Value $116B
National Health Investors (NHI) has a market value of $3.0B and Prologis (PLD) $116B. Over the last year, with dividends, NHI moved -15.7% and PLD +4.6%. The P/E is 4.3 for NHI and 27.7 for PLD. Dividend yield: NHI 5.93%, PLD 3.37%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
NHI$3.0B
PLD$116B
PLD is 39 times NHI
Revenue, 12 months
NHI$456M
PLD$9.2B
PLD is 20 times NHI
Net income, 12 months
NHI$697M
PLD$4.2B
PLD is 6.0 times NHI
Operating margin
NHI–
PLD54.7%
ROIC
NHI–
PLD5.3%
P/E
NHI4.3
PLD27.7
PLD is 6.4 times NHI
Dividend yield
NHI5.9%
PLD3.4%
2.5 points apart
5-year return
NHI+45.5%
PLD-3.5%
49.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
NHI+45.5%
PLD-3.5%
| Period | NHIWith dividends | PLDWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | -15.7%Price -19.8% | +4.6%Price +1.4% |
| 3 years since November 17, 2023 | +35.5%+10.7% a yearPrice +16.3% | +25.4%+7.8% a yearPrice +13.8% |
| 5 years since November 17, 2021 | +45.5%+7.8% a yearPrice +9.6% | -3.5%-0.7% a yearPrice -16.7% |
| 10 years since November 18, 2016 | +57.0%+4.6% a yearPrice -11.2% | +239.4%+13.0% a yearPrice +155.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
NHINational Health InvestorsPLDPrologis
| Price | $62.43 | $125.22 |
|---|---|---|
| Market value | $3.0B | $116B |
| Enterprise value (EV) | – | $151B |
| P/E | 4.3 | 27.7 |
| P/E, 5-year median | 23.6 | 35.9 |
| P/B | 1.5 | 2.2 |
| EV/EBIT | – | 30.0 |
| Free cash flow yield | – | – |
| Revenue, 12 months | $456M | $9.2B |
|---|---|---|
| Net income, 12 months | $697M | $4.2B |
| Free cash flow, 12 months | -$57M | – |
| Earnings per share, 12 months | $14.24 | $4.49 |
| Revenue growth, year on year | 12.1% | 7.2% |
| Revenue growth a year, past | +2.5%over 5 years | +14.6%over 5 years |
| EPS growth a year, past | -6.1%over 5 years | +12.1%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | 54.7% |
| Net margin | 153.0% | 45.8% |
| ROIC | – | 5.3% |
| ROE | 42.6% | 7.9% |
| Cash | $278M | $1.8B |
|---|---|---|
| Total debt | $1.1B | $36.4B |
| Net debt / EBITDA | – | 4.5 |
| Interest cover | – | 4.8× |
| Dividend yield | 5.9% | 3.4% |
|---|---|---|
| Dividend per share, 12 months | $3.70 | $4.22 |
| Dividend growth a year, past | -3.6%over 5 years | +11.7%over 5 years |
| Buyback yield | – | – |
| Shareholder yield | 5.9% | 3.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Prologis ($116B) is about 38.5 times National Health Investors ($3.0B), at today's prices.
Since November 18, 2016, NHI's price moved -11.2% and PLD's +155.7%. With dividends: NHI +57.0% (+4.6% a year), PLD +239.4% (+13.0% a year). Past returns do not predict future ones.
The dividend yield at today's price is 5.93% for National Health Investors and 3.37% for Prologis. Over the last twelve months they paid $3.70 and $4.22 per share.
At today's price, the P/E is 4.3 for NHI and 27.7 for PLD. The median of the last five years was 23.6 and 35.9, which shows where each stands against its own past.
Over the last twelve months, the net margin was 153.0% for National Health Investors and 45.8% for Prologis, and the operating margin – and 54.7%. Revenue was $456M and $9.2B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.